应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ABVX Abivax S.A.
休市中 07-18 16:00:00 EDT
9.95
-0.39
-3.77%
盘后
10.82
+0.87
+8.74%
19:56 EDT
最高
10.32
最低
9.86
成交量
62.00万
今开
10.32
昨收
10.34
日振幅
4.45%
总市值
6.32亿
流通市值
2.82亿
总股本
6,347万
成交额
620.85万
换手率
2.19%
流通股本
2,829万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Abivax盘中异动 早盘急速上涨5.82%报10.46美元
市场透视 · 07-17 13:42
Abivax盘中异动 早盘急速上涨5.82%报10.46美元
Abivax股价拉升12.15% 市值涨7654万美元
市场透视 · 07-16
Abivax股价拉升12.15% 市值涨7654万美元
Abivax盘中异动 急速拉升5.44%报8.72美元
市场透视 · 07-14
Abivax盘中异动 急速拉升5.44%报8.72美元
Abivax盘中异动 早盘股价大涨5.29%
市场透视 · 07-09
Abivax盘中异动 早盘股价大涨5.29%
Abivax盘中异动 股价大涨5.87%报8.11美元
市场透视 · 07-02
Abivax盘中异动 股价大涨5.87%报8.11美元
Abivax盘中异动 早盘股价大涨5.05%报7.77美元
市场透视 · 06-30
Abivax盘中异动 早盘股价大涨5.05%报7.77美元
Abivax盘中异动 下午盘大幅上涨5.15%
市场透视 · 06-27
Abivax盘中异动 下午盘大幅上涨5.15%
Abivax盘中异动 下午盘急速拉升5.19%
市场透视 · 06-25
Abivax盘中异动 下午盘急速拉升5.19%
Abivax盘中异动 早盘股价大涨5.07%
市场透视 · 06-24
Abivax盘中异动 早盘股价大涨5.07%
Abivax盘中异动 大幅下跌7.69%报6.20美元
市场透视 · 06-17
Abivax盘中异动 大幅下跌7.69%报6.20美元
Abivax盘中异动 大幅下跌5.16%报6.62美元
市场透视 · 06-16
Abivax盘中异动 大幅下跌5.16%报6.62美元
Abivax盘中异动 股价大跌5.39%报7.02美元
市场透视 · 06-12
Abivax盘中异动 股价大跌5.39%报7.02美元
Abivax盘中异动 大幅跳水8.51%
市场透视 · 06-11
Abivax盘中异动 大幅跳水8.51%
Abivax盘中异动 急速跳水5.13%报7.77美元
市场透视 · 06-09
Abivax盘中异动 急速跳水5.13%报7.77美元
Abivax盘中异动 早盘股价大涨5.03%报8.56美元
市场透视 · 06-06
Abivax盘中异动 早盘股价大涨5.03%报8.56美元
Abivax盘中异动 大幅拉升6.14%报6.74美元
市场透视 · 06-03
Abivax盘中异动 大幅拉升6.14%报6.74美元
Abivax盘中异动 快速拉升7.48%报6.47美元
市场透视 · 06-02
Abivax盘中异动 快速拉升7.48%报6.47美元
Abivax盘中异动 早盘大幅上涨6.53%报6.04美元
市场透视 · 05-27
Abivax盘中异动 早盘大幅上涨6.53%报6.04美元
Abivax盘中异动 早盘股价大跌5.45%报5.72美元
市场透视 · 05-23
Abivax盘中异动 早盘股价大跌5.45%报5.72美元
Abivax盘中异动 早盘快速上涨5.15%
市场透视 · 05-22
Abivax盘中异动 早盘快速上涨5.15%
加载更多
公司概况
公司名称:
Abivax S.A.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Abivax Sa是一家于2013年12月4日根据法国法律注册成立。该公司是一家临床阶段的生物技术公司,专注于开发利用人体自然调节机制来调节慢性炎症性疾病患者免疫反应的疗法。该公司目前正在3期临床试验中评估主要候选药物奥贝法兹莫德,用于治疗成人中度至重度活动性溃疡性结肠炎。
发行价格:
--
{"stockData":{"symbol":"ABVX","market":"US","secType":"STK","nameCN":"Abivax S.A.","latestPrice":9.95,"timestamp":1752868800000,"preClose":10.34,"halted":0,"volume":620004,"hourTrading":{"tag":"盘后","latestPrice":10.8199,"preClose":9.95,"latestTime":"19:56 EDT","volume":30617,"amount":332502.47,"timestamp":1752882973785},"delay":0,"floatShares":28292614,"shares":63471933,"eps":-3.17854,"marketStatus":"休市中","change":-0.39,"latestTime":"07-18 16:00:00 EDT","open":10.32,"high":10.32,"low":9.86,"amount":6208495.614552001,"amplitude":0.044487,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.17854,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":7,"adr":0,"adrRate":1,"listingDate":1697774400000,"exchange":"NASDAQ","adjPreClose":10.34,"preHourTrading":{"tag":"盘前","latestPrice":10.37,"preClose":10.34,"latestTime":"09:25 EDT","volume":2952,"amount":30964.260095999998,"timestamp":1752845143344},"postHourTrading":{"tag":"盘后","latestPrice":10.8199,"preClose":9.95,"latestTime":"19:56 EDT","volume":30617,"amount":332502.47,"timestamp":1752882973785},"volumeRatio":0.608277504646422},"requestUrl":"/m/hq/s/ABVX","defaultTab":"news","newsList":[{"id":"2552482119","title":"Abivax盘中异动 早盘急速上涨5.82%报10.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552482119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552482119?lang=zh_cn&edition=full","pubTime":"2025-07-17 21:42","pubTimestamp":1752759735,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日21时42分,Abivax股票出现波动,股价大幅拉升5.82%。截至发稿,该股报10.46美元/股,成交量6.9625万股,换手率0.11%,振幅4.55%。Abivax股票所在的生物技术行业中,整体涨幅为0.29%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071721421597a9d736&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071721421597a9d736&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2551125161","title":"Abivax股价拉升12.15% 市值涨7654万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551125161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551125161?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:31","pubTimestamp":1752672687,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时31分,Abivax股票出现波动,股价急速拉升12.15%。截至发稿,该股报9.93美元/股,成交量27.2193万股,换手率0.43%,振幅2.71%。Abivax股票所在的生物技术行业中,整体涨幅为0.40%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716213127a44edf08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716213127a44edf08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2551187374","title":"Abivax盘中异动 急速拉升5.44%报8.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551187374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551187374?lang=zh_cn&edition=full","pubTime":"2025-07-14 22:56","pubTimestamp":1752505010,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日22时56分,Abivax股票出现波动,股价快速拉升5.44%。截至发稿,该股报8.72美元/股,成交量19.3795万股,换手率0.31%,振幅6.65%。Abivax股票所在的生物技术行业中,整体涨幅为1.07%。其相关个股中,Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.涨幅较大,Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃,换手率分别为1942.63%、944.79%、586.05%,振幅较大的相关个股有Promis Neurosciences Inc.、Dare Bioscience, Inc.、Sonnet Biotherapeutics Holdings, Inc.,振幅分别为210.04%、157.85%、125.73%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714225650a6a91353&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714225650a6a91353&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2550538766","title":"Abivax盘中异动 早盘股价大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550538766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550538766?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:39","pubTimestamp":1752068364,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时39分,Abivax股票出现异动,股价快速上涨5.29%。截至发稿,该股报8.16美元/股,成交量2.669万股,换手率0.04%,振幅2.26%。Abivax股票所在的生物技术行业中,整体涨幅为1.16%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213924953c360f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213924953c360f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2548909448","title":"Abivax盘中异动 股价大涨5.87%报8.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548909448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548909448?lang=zh_cn&edition=full","pubTime":"2025-07-02 21:34","pubTimestamp":1751463295,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日21时34分,Abivax股票出现波动,股价大幅上涨5.87%。截至发稿,该股报8.11美元/股,成交量3942股,换手率0.01%,振幅2.76%。Abivax股票所在的生物技术行业中,整体跌幅为0.05%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507022134559533fdeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507022134559533fdeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2547090575","title":"Abivax盘中异动 早盘股价大涨5.05%报7.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547090575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547090575?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:50","pubTimestamp":1751291453,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时50分,Abivax股票出现异动,股价大幅上涨5.05%。截至发稿,该股报7.77美元/股,成交量6.2187万股,换手率0.10%,振幅3.04%。Abivax股票所在的生物技术行业中,整体涨幅为0.14%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506302150549794abdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506302150549794abdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2546726142","title":"Abivax盘中异动 下午盘大幅上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546726142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546726142?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:01","pubTimestamp":1751050900,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时01分,Abivax股票出现异动,股价快速上涨5.15%。截至发稿,该股报7.55美元/股,成交量16.7031万股,换手率0.26%,振幅4.04%。Abivax股票所在的生物技术行业中,整体跌幅为0.73%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628030141a4c1bfec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628030141a4c1bfec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2546247736","title":"Abivax盘中异动 下午盘急速拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546247736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546247736?lang=zh_cn&edition=full","pubTime":"2025-06-26 01:02","pubTimestamp":1750870921,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日01时02分,Abivax股票出现波动,股价快速拉升5.19%。截至发稿,该股报7.00美元/股,成交量6.0699万股,换手率0.10%,振幅5.86%。机构评级方面,在所有12家参与评级的机构中,92%的券商给予买入建议,8%的券商给予持有建议,无券商给予卖出建议。Abivax股票所在的生物技术行业中,整体跌幅为0.72%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626010201a71d69b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626010201a71d69b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2545123592","title":"Abivax盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545123592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545123592?lang=zh_cn&edition=full","pubTime":"2025-06-24 22:21","pubTimestamp":1750774884,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日22时21分,Abivax股票出现波动,股价急速拉升5.07%。截至发稿,该股报6.42美元/股,成交量1.6098万股,换手率0.03%,振幅3.35%。Abivax股票所在的生物技术行业中,整体涨幅为0.76%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506242221259529b565&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506242221259529b565&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2544399971","title":"Abivax盘中异动 大幅下跌7.69%报6.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544399971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544399971?lang=zh_cn&edition=full","pubTime":"2025-06-17 23:58","pubTimestamp":1750175914,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日23时58分,Abivax股票出现异动,股价大幅下挫7.69%。截至发稿,该股报6.20美元/股,成交量5.618万股,换手率0.09%,振幅3.42%。Abivax股票所在的生物技术行业中,整体跌幅为0.85%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617235834a4aead82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617235834a4aead82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2543609916","title":"Abivax盘中异动 大幅下跌5.16%报6.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543609916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543609916?lang=zh_cn&edition=full","pubTime":"2025-06-16 23:18","pubTimestamp":1750087106,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日23时18分,Abivax股票出现波动,股价快速跳水5.16%。截至发稿,该股报6.62美元/股,成交量17.3617万股,换手率0.27%,振幅3.80%。Abivax股票所在的生物技术行业中,整体跌幅为0.38%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616231826a4ac6035&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616231826a4ac6035&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2543546492","title":"Abivax盘中异动 股价大跌5.39%报7.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543546492","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543546492?lang=zh_cn&edition=full","pubTime":"2025-06-13 00:39","pubTimestamp":1749746344,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日00时39分,Abivax股票出现异动,股价快速跳水5.39%。截至发稿,该股报7.02美元/股,成交量4.4715万股,换手率0.07%,振幅7.82%。Abivax股票所在的生物技术行业中,整体涨幅为0.93%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613003905a705b04d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613003905a705b04d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2542536631","title":"Abivax盘中异动 大幅跳水8.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542536631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542536631?lang=zh_cn&edition=full","pubTime":"2025-06-11 23:58","pubTimestamp":1749657527,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日23时58分,Abivax股票出现波动,股价急速下挫8.51%。截至发稿,该股报7.20美元/股,成交量3.8217万股,换手率0.06%,振幅2.44%。Abivax股票所在的生物技术行业中,整体涨幅为0.41%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611235847977b3074&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611235847977b3074&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2542335413","title":"Abivax盘中异动 急速跳水5.13%报7.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542335413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542335413?lang=zh_cn&edition=full","pubTime":"2025-06-09 23:09","pubTimestamp":1749481775,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日23时09分,Abivax股票出现异动,股价快速下跌5.13%。截至发稿,该股报7.77美元/股,成交量9.0449万股,换手率0.14%,振幅6.47%。Abivax股票所在的生物技术行业中,整体涨幅为0.70%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609230935a4a094c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609230935a4a094c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2541863854","title":"Abivax盘中异动 早盘股价大涨5.03%报8.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541863854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541863854?lang=zh_cn&edition=full","pubTime":"2025-06-06 21:36","pubTimestamp":1749217017,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日21时36分,Abivax股票出现异动,股价急速上涨5.03%。截至发稿,该股报8.56美元/股,成交量6949股,换手率0.01%,振幅2.33%。Abivax股票所在的生物技术行业中,整体涨幅为0.74%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606213657977471c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606213657977471c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2540772411","title":"Abivax盘中异动 大幅拉升6.14%报6.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540772411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540772411?lang=zh_cn&edition=full","pubTime":"2025-06-03 21:45","pubTimestamp":1748958323,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日21时45分,Abivax股票出现波动,股价快速拉升6.14%。截至发稿,该股报6.74美元/股,成交量6.927万股,换手率0.11%,振幅4.72%。Abivax股票所在的生物技术行业中,整体涨幅为0.21%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603214523a6f8c077&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603214523a6f8c077&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2540795116","title":"Abivax盘中异动 快速拉升7.48%报6.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540795116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540795116?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:36","pubTimestamp":1748871377,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时36分,Abivax股票出现异动,股价急速上涨7.48%。截至发稿,该股报6.47美元/股,成交量1.33万股,换手率0.02%,振幅0.75%。Abivax股票所在的生物技术行业中,整体涨幅为0.71%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213618a496bd1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213618a496bd1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2538146755","title":"Abivax盘中异动 早盘大幅上涨6.53%报6.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538146755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538146755?lang=zh_cn&edition=full","pubTime":"2025-05-27 21:31","pubTimestamp":1748352685,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日21时31分,Abivax股票出现异动,股价快速上涨6.53%。截至发稿,该股报6.04美元/股,成交量2.7982万股,换手率0.04%,振幅0.18%。Abivax股票所在的生物技术行业中,整体涨幅为0.65%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527213125a48e738b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527213125a48e738b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2537130968","title":"Abivax盘中异动 早盘股价大跌5.45%报5.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537130968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537130968?lang=zh_cn&edition=full","pubTime":"2025-05-23 22:19","pubTimestamp":1748009949,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日22时19分,Abivax股票出现波动,股价快速跳水5.45%。截至发稿,该股报5.72美元/股,成交量3.5536万股,换手率0.06%,振幅3.31%。Abivax股票所在的生物技术行业中,整体涨幅为0.00%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523221909a6ea6928&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523221909a6ea6928&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2537940853","title":"Abivax盘中异动 早盘快速上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537940853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537940853?lang=zh_cn&edition=full","pubTime":"2025-05-22 22:43","pubTimestamp":1747925011,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日22时43分,Abivax股票出现异动,股价大幅拉升5.15%。截至发稿,该股报6.12美元/股,成交量2.8094万股,换手率0.04%,振幅5.84%。Abivax股票所在的生物技术行业中,整体跌幅为0.52%。公司正在 3 期临床试验中评估其候选药物 obefazimod 用于治疗成人中度至重度活动性溃疡性结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052222433194ff4d82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052222433194ff4d82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abivax.com","stockEarnings":[{"period":"1week","weight":0.2031},{"period":"1month","weight":0.6446},{"period":"3month","weight":0.5547},{"period":"6month","weight":0.6153},{"period":"1year","weight":-0.2257},{"period":"ytd","weight":0.3593}],"compareEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":0.0504},{"period":"3month","weight":0.1922},{"period":"6month","weight":0.0502},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.0708}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Abivax Sa是一家于2013年12月4日根据法国法律注册成立。该公司是一家临床阶段的生物技术公司,专注于开发利用人体自然调节机制来调节慢性炎症性疾病患者免疫反应的疗法。该公司目前正在3期临床试验中评估主要候选药物奥贝法兹莫德,用于治疗成人中度至重度活动性溃疡性结肠炎。","exchange":"NASDAQ","name":"Abivax S.A.","nameEN":"Abivax S.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Abivax S.A.(ABVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Abivax S.A.(ABVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Abivax S.A.,ABVX,Abivax S.A.股票,Abivax S.A.股票老虎,Abivax S.A.股票老虎国际,Abivax S.A.行情,Abivax S.A.股票行情,Abivax S.A.股价,Abivax S.A.股市,Abivax S.A.股票价格,Abivax S.A.股票交易,Abivax S.A.股票购买,Abivax S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Abivax S.A.(ABVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Abivax S.A.(ABVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}